Followers | 255 |
Posts | 19061 |
Boards Moderated | 1 |
Alias Born | 12/02/2014 |
![](https://investorshub.advfn.com/uicon/507984.png?cb=1467217226)
Thursday, April 06, 2023 6:08:31 PM
Apollo Hospitals correspondence is ongoing. With their input and collaboration, we are also communicating for designing the trials, in conjuction. Official $GSTC PR’s will be out when legally possible. It’s been a wait, but we are closing in.
— GlobeStar Therapeutics (@officialGSTC) January 26, 2023
With a follow up Tweet here:
(THREAD 1/4) Good afternoon $GSTC shareholders! Our associates in India are diligently working to give us approval and we expect to hear from them this month for answers.
— GlobeStar Therapeutics (@officialGSTC) February 3, 2023
Apollo Hospitals- Excellence in Healthcare
Apollo Hospitals is leading the multispecialty healthcare unit with best class treatments.
With an ageing and expanding population of more than 1.3 billion, to provide healthcare to them was a rising challenge. More than that was bringing medical care to the remote areas of India, where most of the population resides, and has very low access to healthcare. It was time India’s healthcare needed transformation.
https://theenterpriseworld.com/apollo-hospitals-excellence-in-healthcare/
Clinical Trials
ARI is India’s first and single largest site solutions organization (SSO) having experience in coordinating the conduct of over 800 clinical trials across 10 locations, various therapeutic disciplines over the last 14 years. With the current strength of almost 80 certified and experienced Clinical Research Coordinators and 200 Principal Investigators on its panel across 15 sites, ARI ensures ethical conduct of clinical research across the hospital group. ARI conducts phase II, III and IV clinical trials, of which 80% are global multi-¬centric trials.
Apollo Multispeciality Hospitals as part of ARI has developed the capability to now conduct clinical studies for drugs, devices, software applications and others. Further, ARI works with its clients and partners with a variety of creative business models to enable progressive and quality research.
The Institutional Ethics Committees in all the 10 Apollo Hospital locations are registered with the Drug Control General of India (DCGI). ARI currently is coordinating the conduct of almost 100 clinical studies across Apollo Multispeciality Hospitals, Kolkata.
https://kolkata.apollohospitals.com/academics-research/research-innovations/clinical-research/
![Bullish](/static/images/ih2-bull.png)
Recent GSTC News
- Form NT 10-Q - Notification of inability to timely file Form 10-Q or 10-QSB • Edgar (US Regulatory) • 05/17/2024 08:05:07 PM
- Form NT 10-Q - Notification of inability to timely file Form 10-Q or 10-QSB • Edgar (US Regulatory) • 02/15/2024 04:33:13 PM
- Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405] • Edgar (US Regulatory) • 01/19/2024 10:13:47 PM
- Form NT 10-K - Notification of inability to timely file Form 10-K 405, 10-K, 10-KSB 405, 10-KSB, 10-KT, or 10-KT405 • Edgar (US Regulatory) • 01/02/2024 09:21:47 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 11/13/2023 05:32:02 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 08/17/2023 08:01:04 PM
- Form NT 10-Q - Notification of inability to timely file Form 10-Q or 10-QSB • Edgar (US Regulatory) • 08/14/2023 08:31:39 PM
FEATURED Cannabix Technologies to Deliver Innovative Breath Logix Alcohol Screening Device to Texas, USA • Jul 29, 2024 9:07 AM
INDEXR AI Merges With Moon Equity Holdings Corp. (MONI), Creating a Leading-edge Technology Company • MONI • Jul 29, 2024 9:59 AM
BNCM AND DELEX UNVEIL POST-MERGER MANAGEMENT PLANS • BNCM • Jul 29, 2024 9:00 AM
Glidelogic Corp. Announces Revolutionary AI-Generated Content Copyright Protection Solution • GDLG • Jul 26, 2024 12:30 PM
Southern Silver Files NI43-101 Technical Report for its Updated Preliminary Economic Assessment for the Cerro Las Minitas Project • SSV • Jul 25, 2024 8:00 AM
Greenlite Ventures Completes Agreement with No Limit Technology • GRNL • Jul 19, 2024 10:00 AM